SYGGF (SYGGF) Stock Price & Analysis
SYGGF (SYGGF) rose 0.00% to USD 0 as of June 10, 2026 at 07:40 UTC, according to Nexqual real-time market data.
SYGGF last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 10,000 shares. Market capitalization is $110,266, with a 52-week range of USD 0–0.01 (PNK). Source: Nexqual, June 10, 2026 at 07:40 UTC.
Key Statistics (as of June 10, 2026 at 07:40 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.01 |
| Volume | 10,000 shares |
| Market Cap | $110,266 |
| Exchange | PNK |
Technical Analysis (SYGGF)
Nexqual's technical model rates SYGGF "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:40 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (SYGGF)
Wall Street analysts rate SYGGF "None", per Nexqual as of June 10, 2026 at 07:40 UTC.
| Consensus Rating | None |
|---|
Earnings (SYGGF)
Source: Nexqual, June 10, 2026 at 07:40 UTC.
Financials & Fundamentals (SYGGF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -31.85% |
| Current Ratio | 25.88 |
| Total Cash | $4.55M |
| Total Debt | $0 |
| Free Cash Flow | $-21.26M |
Source: Nexqual, June 10, 2026 at 07:40 UTC.
Financial Health Score (SYGGF)
Nexqual rates SYGGF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 07:40 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $5M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$24M |
| Efficiency | Critical — ROE -32%, ROA -23.9% |
Ownership (SYGGF)
| Insider Ownership | +0.57% |
|---|---|
| Institutional Ownership | +87.22% |
| Shares Outstanding | 1.10B |
| Float | 133.84M |
Source: Nexqual, June 10, 2026 at 07:40 UTC.
Leadership (SYGGF)
SYGGF is led by Joseph Tregonning Colliver F.C.A. (age 45), CEO & Executive Director, per Nexqual as of June 10, 2026 at 07:40 UTC.
| CEO & Executive Director | Joseph Tregonning Colliver F.C.A. (age 45) |
|---|---|
| Executive Chairman | Mark Parry-Billings (age 61) |
| Finance Director | Andy Lee |
| CMO & Head of Scientific Affairs | Marcin Mankowski |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ZHCLF | Zenith Cap Corp. | USD 0.05 | ▲ 0% |
| BETRF | BETTERLIFE PHARMA INC. | USD 0.05 | ▲ 14.42% |
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
| INNMF | Amplia Therapeutics Ltd. | USD 0.1 | ▲ 5.26% |
| PKTX | ProtoKinetix, Inc. | USD 0.01 | ▼ 6.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:40 UTC. This page is informational and not investment advice.